Home/ Pharmacology Academy/ Decongestants: how they work and key risks

Decongestants: how they work and key risks

Understand Decongestants: mechanism of action, key risks and questions for your clinician. Plain-language explanations with sources and ingredient links.

· Medical writer · Published

Medical review has not been recorded for this version.

AI tools helped draft this article. Its sources and review status are shown here.

Editorial policy

TL;DR

  • Decongestants are vasoconstrictors: oxymetazoline (Afrin, Vicks Sinex), xylometazoline (Otrivin), pseudoephedrine (Sudafed) and phenylephrine (Sudafed PE) are the everyday ones.
  • They tighten the blood vessels in your nasal lining, so the swollen tissue shrinks and air can move through again. The cold or allergy underneath is untouched.
  • After about three to five days, sprays start to backfire — the nose rebounds harder than it was congested. This has a name (rhinitis medicamentosa) and a clinical literature behind it.
  • In 2023 an FDA advisory committee concluded that oral phenylephrine at over-the-counter doses essentially does not work as a nasal decongestant. Pseudoephedrine still does, which is why it lives behind the pharmacy counter.
  • Pseudoephedrine with an MAOI antidepressant is an emergency-room interaction, not a "be careful" one. Avoid it absolutely.

What are decongestants, really?

Decongestants are the drugs that unblock a stuffy nose by squeezing the blood vessels inside it. They are not antihistamines, they are not antibiotics, and they are not cold cures. They are vasoconstrictors with a single, narrow job: take the swelling out of your nasal lining so you can breathe through your nose again.

You meet them in two formats. The first is topical — sprays and drops you put directly up the nose. Oxymetazoline (Afrin, Vicks Sinex, Nasivion) and xylometazoline (Otrivin, Sinutab) are the household names; they act locally, kick in within minutes, and last most of the day. Naphazoline (Privine) belongs to the same family but is largely on its way out for nasal use because it gets absorbed into the bloodstream more aggressively than its cousins.

The second is systemic — tablets you swallow. Pseudoephedrine (Sudafed, Actifed) is the classic. In the United States it lives behind the pharmacy counter, not because it is dangerous in the usual sense, but because it is a precursor for illicit methamphetamine — the 2005 Combat Methamphetamine Epidemic Act moved it off the open shelf. Phenylephrine (Sudafed PE, plus a long list of DayQuil / NyQuil-style combination products) was the replacement on the open shelf. We will see in a moment that this replacement has not aged well.

The single most useful thing to keep in your head: decongestants treat the symptom of congestion, not the cause. The virus, the allergen, the sinus infection — all untouched. You are turning down the volume on stuffiness, not switching the music off.

How they work — the simple version

The lining inside your nose is shot through with blood vessels. When you catch a cold or have an allergic reaction, your immune system tells those vessels to dilate. The tissue swells with fluid, the airway between your nostrils narrows, and air can no longer move through. That is what "congestion" actually is — not mucus blocking a pipe, but a soft tunnel that has swollen almost shut around itself.

Decongestants act on tiny switches on the walls of those blood vessels called alpha-adrenergic receptors (α1 and α2). These are the same receptors adrenaline uses when you are scared or running for a bus — and one of adrenaline's standard moves is to constrict blood vessels in non-essential places. Decongestants imitate that signal, locally and selectively. The vessels in the nasal lining clamp down, blood flow drops, the swelling recedes, and the tunnel reopens. Topical oxymetazoline and xylometazoline pull this off within 5–10 minutes and keep the effect going for 6–12 hours, which is why they feel close to miraculous on the first night of a head cold.

Oral decongestants work the same way at the receptor level but reach the nose through the bloodstream. That makes them slower to kick in and weaker on the strictly nasal effect, but broader in coverage — they also constrict vessels in the sinuses and around the Eustachian tube, the channel that equalizes pressure in your middle ear. This is why pseudoephedrine is famously the airplane-ear drug.

Now for the awkward part of the story. Oral phenylephrine uses the same receptors and should, on paper, do the same job. The problem is your liver. When you swallow phenylephrine, the gut and the liver chew through almost all of it before it ever reaches the blood vessels of the nose — the technical name is extensive first-pass metabolism. In 2023 the FDA's Nonprescription Drugs Advisory Committee reviewed every halfway-decent study and concluded that oral phenylephrine at over-the-counter doses is not effective as a nasal decongestant; the studies that originally got it onto the shelves did not hold up to modern reanalysis. The topical phenylephrine drops still work fine — but the tablets that ride along inside half the cough-and-cold combination products on the pharmacy shelf almost certainly are not pulling their weight.

What else they do to your body, beyond clearing your nose

Once you understand the mechanism — "imitate adrenaline at blood vessels" — the side effects stop looking like a random list and start looking inevitable. You told the blood vessels to constrict. Blood vessels do not only live in your nose.

The rebound trap (rhinitis medicamentosa). This is the single most important thing in this article. After about three to five days of regular topical decongestant use, the alpha-adrenergic receptors in your nasal lining start to push back. They downregulate — there are fewer of them, and the remaining ones are less responsive. When the dose wears off, the vessels do not return to baseline; they over-dilate, and the nose feels even more blocked than before. So you spray again. The cycle locks in. The clinical name is rhinitis medicamentosa (or "rebound congestion"), and Ramey, Bailen and Lockey laid out the mechanism cleanly in the Journal of Investigational Allergology and Clinical Immunology in 2006. This is not addiction in the psychiatric sense and it is not an allergy — it is physiological tolerance, and it happens to a meaningful share of people who use oxymetazoline or xylometazoline for more than about a week. Coming off is unpleasant: a few days to two weeks of stuffy misery while the receptors reset. The three-to-five-day rule on every spray bottle is not legal small print. It is the actual usable window.

Blood pressure and heart rate. Pseudoephedrine can nudge systolic blood pressure upward, speed the heart up, and produce a wired, slightly jittery feeling — the closest healthy people get to too much coffee plus too much adrenaline at the same time. For somebody whose blood pressure is already on the edge, an over-the-counter cold tablet can be the dose that pushes a normal reading into a "call your doctor" reading.

Sleep, mood, and nerves. That same sympathetic push gives oral decongestants their reputation for keeping people awake and making anxious people more anxious. This is why so many cold-and-flu products come in "daytime" and "nighttime" versions — the nighttime one drops the decongestant and adds a sedating H1 antihistamine instead.

Kids. Children, especially under two, are not just small adults. Their blood vessels and central nervous systems are more sensitive to alpha-agonists. Naphazoline has the worst reputation here — even ordinary nose-drop volumes have caused central nervous system depression, slow heart rate and dangerous drops in body temperature in toddlers — but the entire class is treated with caution in young children. Following the FDA's 2008 safety review, over-the-counter cough-and-cold products containing decongestants are not recommended for children under two, and the major manufacturers voluntarily relabeled them as not for use under four.

Eyes. Alpha-agonists also dilate the pupil slightly. For most people that is invisible. For someone with anatomically narrow angles in the eye, a decongestant can be the trigger for an acute angle-closure glaucoma attack — sudden eye pain, blurred vision, halos, headache, nausea. Rare, real, and emergency-room serious when it happens.

What people usually take with them, and why

Decongestants almost never travel alone. Walk into any pharmacy and look at the cold aisle — you will see tablet after tablet, sachet after sachet, that pairs a decongestant with one or more other ingredients. The logic behind these combinations is straightforward if you read the back of the box.

  • + H1 antihistamine. For colds with a lot of runny nose and sneezing, or for allergic congestion, an antihistamine like loratadine, cetirizine or chlorpheniramine deals with the histamine half of the picture while the decongestant deals with the vascular half. Older sedating antihistamines (chlorpheniramine, diphenhydramine) also help you sleep through it. We have a full article on this class — see H1 antihistamines.
  • + Paracetamol/acetaminophen. For the aches and fever that come with a real cold or flu. See paracetamol for how that side of the combination works.
  • + An NSAID. Ibuprofen and naproxen tackle the same headache-and-bodyache territory through a different mechanism — see NSAIDs. Pairing the two is common in flu-relief products.
  • + A cough suppressant or expectorant. Dextromethorphan for dry cough, guaifenesin for the productive kind. The decongestant is dealing with the nose; the cough drug is dealing with the throat.

None of this stacking is wrong in principle. The catch is that it makes accidental double-dosing easy: if you take a multi-symptom cold product and a separate paracetamol, you can quietly cross the paracetamol safety line. Read every label.

Then there are the interactions that matter clinically, not just inconveniently.

  • MAOI antidepressants (phenelzine, tranylcypromine, isocarboxazid, and the antibiotic linezolid which has MAOI activity) plus an oral decongestant — pseudoephedrine especially — is a textbook hypertensive crisis waiting to happen. Blood pressure can shoot up to stroke-level numbers in hours. This is an absolute do-not-combine, not a "use caution." A washout of at least two weeks after the MAOI is the standard rule.
  • Beta-blockers plus oral decongestants is a subtler version of the same problem. With the beta receptors blocked, the alpha vasoconstrictor effect of the decongestant becomes unopposed, and blood pressure can rise more sharply than it would in someone not on a beta-blocker. Not catastrophic, but real, and worth knowing if you are managing hypertension.
  • Stimulants and ADHD medications (amphetamines, methylphenidate) pile onto the same sympathetic system and amplify the cardiovascular and nervous-system effects.
  • Other cold products you already took — yes, again. The most common decongestant overdose is not malicious; it is a person taking Sudafed and a multi-symptom product together because they did not notice both contained pseudoephedrine.

Red flags — when to call a doctor

Decongestants are some of the most-used drugs in the world, and the vast majority of people who use them for a few days never have a problem. But there are signals that mean stop the drug, and signals that mean go to an emergency room.

  • Sudden severe headache, vision changes, chest pain or a feeling of pounding in the chest after a decongestant dose — possible hypertensive reaction or, in rare cases, cardiovascular event. Get evaluated.
  • Eye pain, blurry vision, halos around lights, nausea — could be acute angle-closure glaucoma. Emergency.
  • A child under two given any decongestant who becomes floppy, unusually sleepy, has a noticeably slow heartbeat or unstable temperature — emergency room. Naphazoline drops are the worst offender here historically, but the rule applies to the whole class.
  • You have been using a nasal spray for more than five days and your nose feels worse the moment the dose wears off — that is rhinitis medicamentosa beginning. Stop the spray, switch to saline irrigation, and if it does not settle in a week or two see a clinician about a short course of intranasal corticosteroid.
  • You have high blood pressure, coronary artery disease, hyperthyroidism, or you are pregnant — talk to a pharmacist or doctor before reaching for an oral decongestant, not after.
  • Congestion that lasts more than ten days, comes with high fever, severe one-sided facial pain, or thick discoloured discharge — that is no longer simple congestion territory. It might be bacterial sinusitis, and decongestants are not the right tool.

Two more population-level red flags worth naming:

Pregnancy. Pseudoephedrine in the first trimester has been associated, in several observational studies, with a small increase in the risk of certain birth defects — most notably gastroschisis. The signal is not enormous, but it is consistent enough that most clinicians steer pregnant patients away from oral decongestants in the first trimester, preferring saline rinses, humidified air, and limited topical use under medical guidance.

Pheochromocytoma. This is a rare adrenal tumour that already floods the body with adrenaline-like hormones. Layering a sympathomimetic on top is a textbook contraindication. If you have been told you have it, you already know.

What people get wrong

"Decongestants treat colds." They do not. They shrink the swollen tissue in your nose so you can breathe more comfortably while a cold runs its course. The virus is unaffected. Cold duration is unchanged. The only thing that changes is how miserable you feel during it.

"Sprays are safe to use as long as you need them." This is the single most damaging myth in this area, and it is the reason rhinitis medicamentosa is so common. The three-to-five-day limit printed on the bottle is not legal caution — it is the actual cutoff before the drug starts working against you. After that window, your nose has begun to push back at the receptor level.

"Phenylephrine tablets work just like Sudafed." They mostly do not. The FDA's 2023 advisory committee meeting concluded that over-the-counter oral phenylephrine is essentially no better than placebo as a nasal decongestant. If you want the oral version that does work, you are looking for pseudoephedrine, which lives behind the pharmacy counter in the US — you need to ask, and you will be asked for ID. If a clear nose matters to you on a flight, it is worth that small inconvenience.

"Nasal spray dependence is something doctors made up." Rhinitis medicamentosa has been described in the medical literature for decades. It is not psychological dependence in the addiction sense — it is a physiological rebound caused by receptor downregulation, and it shows up reliably enough that allergy clinics see new cases every week. It is one of the most thoroughly documented and least talked-about side effects in over-the-counter medicine.

"Kids' nose drops are safe at any age, they are designed for children." Pediatric formulations exist mainly because the original adult dose was clearly unsafe for small bodies, not because the drug class is intrinsically gentle. For children under two, the answer in nearly every guideline is: no over-the-counter decongestants. Under four, manufacturers themselves voluntarily relabeled their products after the FDA's 2008 review.

"If my nose is blocked, I should reach for a spray." Not necessarily, and not first. For mild congestion — a touch of allergy, a head cold day one — saline irrigation (a neti pot, a squeeze bottle, or simple saline drops) is the right first move. It does not have a side-effect profile worth worrying about, it does not cause rebound, and for many people it is enough. Reach for a real decongestant when congestion is genuinely disrupting sleep, hearing, or the ability to function — not for every sniffle.

"The same spray, all winter long." A pattern worth flagging. Many people keep a bottle of oxymetazoline on the bedside table and use it nightly through the cold months, never connecting the steadily worsening morning stuffiness to the spray itself. If that sounds familiar — it is probably the spray.

The whole class is genuinely useful, used the way it was designed to be used: a few days, for a real problem, with attention to who should not take it. The trouble starts the moment "a few days" stretches into "always."

Ingredients and names around the world

Examples of ingredients discussed in this topic. A shared ingredient does not by itself make medicines interchangeable.

More ingredients and salt forms

Sources

  1. FDA. FDA clarifies results of recent advisory committee meeting on oral phenylephrine. U.S. Food and Drug Administration. September 14, 2023. · 2023
  2. Hatton RC, Winterstein AG, McKelvey RP, Shuster J, Hendeles L. Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Annals of Pharmacotherapy. 2007;41(3):381-390. · PMID 17264159 · 2007
  3. Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. Journal of Investigational Allergology and Clinical Immunology. 2006;16(3):148-155. · PMID 16784007 · 2006
  4. Bousquet J, Schunemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. Journal of Allergy and Clinical Immunology. 2020;145(1):70-80. · PMID 31627910 · 2020
  5. FDA. FDA Statement following CHPA's announcement on nonprescription over-the-counter cough and cold medicines in children. U.S. Food and Drug Administration. October 8, 2008. · 2008
  6. Eccles R. Substitution of phenylephrine for pseudoephedrine as a nasal decongestant. An illogical way to control methamphetamine abuse. British Journal of Clinical Pharmacology. 2007;63(1):10-14. · PMID 17116124 · 2007
  7. Werler MM. Teratogen update: pseudoephedrine. Birth Defects Research Part A: Clinical and Molecular Teratology. 2006;76(6):445-452. · PMID 16933214 · 2006
  8. Salerno SM, Jackson JL, Berbano EP. Effect of oral pseudoephedrine on blood pressure and heart rate: a meta-analysis. Archives of Internal Medicine. 2005;165(15):1686-1694. · PMID 16087815 · 2005
  9. US Drug Enforcement Administration. Combat Methamphetamine Epidemic Act of 2005 — General information regarding the legal requirements for the sale and purchase of scheduled listed chemical products under the CMEA. · 2006

Medical writer

Not a doctor. I run pill2trip.com — explaining pharmacology in plain language, grounded in primary sources.